Sign in

Research summary ·

Systematic review of Leber's hereditary optic neuropathy - Clinical diagnosis, genetics overview and current concepts of treatment.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This is a review that pulls together past studies on an eye disease. The disease is Leber hereditary optic neuropathy, or LHON. LHON is a mitochondrial disease that causes central vision loss. It often strikes young adults. The authors looked at how it is found, its genes, and its care.

What they found

Vision loss often starts in one eye, then the other. It comes from the loss of certain cells in the retina. It is mainly tied to changes in mitochondrial DNA. One of these changes is called m.11778G>A. These changes harm the cells and cause them to die. Idebenone is the first drug approved for LHON in Europe. People who got it early regained some of their vision. A gene therapy called rAAV2/2-ND4 helped both eyes. This was seen even when only one eye got the shot. Gene editing tools may offer ways to correct the faulty genes. Broad gene tests can help find the disease early. Trials named RESTORE and REFLECT point to the value of quick care.

What it means for patients

For a long time, LHON was seen as a disease without treatment. The authors say new treatments now offer fresh hope. They stress that early diagnosis and quick care matter for vision. Gene tests may help doctors find the disease sooner.

Why it is not certain yet

The abstract does not say how many studies were reviewed. It gives no exact numbers on how well each treatment works. Vision gains with idebenone were only partial. Gene editing is described only as a possible future approach. A review can only be as good as the studies in it.

Source

Systematic review of Leber's hereditary optic neuropathy - Clinical diagnosis, genetics overview and current concepts of treatment.

PubMed · PMID 42535808

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Mitochondrial disease publications